Tumor Treating Fields may disrupt tumor communication and induce conditional BRCAness in malignant pleural mesothelioma

Photo by National Cancer Institute / Unsplash

Frontiers in Medicine Published June 1, 2026 Medically reviewed June 1, 2026 DOI ↗ By Dr. Amelia Tan, PhD · Internal Medicine & Chronic Disease

Key Takeaway

Consider TTFields as a theoretical mechanism for disrupting tumor networks in mesothelioma.

This review examines the proposed biological mechanisms of Tumor Treating Fields (TTFields) specifically within the context of malignant pleural mesothelioma. The authors outline a theoretical framework suggesting that TTFields disrupt actin-dependent intercellular tunneling nanotubes. This disruption is hypothesized to sever the tumor's communication and metabolic rescue networks.

The authors further propose that TTFields lead to the downregulation of the Fanconi Anemia-BRCA pathway. This molecular change is described as inducing a state of conditional BRCAness. Additionally, the review discusses immunogenic cell death and chemokine storm as potential effects.

These processes are hypothesized to facilitate the conversion of the tumor microenvironment from an immune cold to a hot phenotype. The review presents these as theoretical concepts rather than established clinical facts. No specific numerical data or adverse event rates are provided in this source.

The authors note that these mechanisms are hypothetical and theoretical. Consequently, the clinical relevance remains uncertain until further validation occurs. Readers should interpret these findings as a conceptual model rather than definitive evidence of efficacy.

Study Details

Study typeSystematic review

EvidenceLevel 1

PublishedMay 2026

View Original Abstract ↓

The therapeutic efficacy in malignant pleural mesothelioma (MPM) is severely hindered by its dense stromal barrier and immunosuppressive microenvironment. Although Tumor Treating Fields (TTFields) have demonstrated significant survival benefits in clinical trials, their underlying mechanisms extend well beyond simple mitotic arrest. This review delineates a “multidimensional biophysical remodeling” atlas of TTFields in MPM. First, we highlight that TTFields physically disrupt actin-dependent intercellular “tunneling nanotubes, ” thereby severing the tumor’s communication and metabolic rescue networks. Second, physical stress downregulates the Fanconi Anemia-BRCA pathway, inducing a state of “conditional BRCAness” that specifically sensitizes tumors to DNA-damaging agents. Finally, this cascade triggers immunogenic cell death and orchestrates a chemokine storm, which is hypothesized to facilitate the conversion of the tumor microenvironment from an immune “cold” to a “hot” phenotype. Collectively, by integrating the physical disintegration of subcellular structures with immunological remodeling, TTFields may offer a hypothetical theoretical framework for overcoming therapeutic resistance in MPM.